1.
Reich K, Armstrong A, Zhu Y, Miller M, You Y, Shen Y-K, Yang Y-W, Foley P, Griffiths C, Strober B. Immunogenicity of Guselkumab (GUS) Among Psoriasis Patients in VOYAGE (VOY) 1&2 Studies. J of Skin [Internet]. 2022Mar.4 [cited 2022Aug.12];6(2):s11. Available from: https://jofskin.org/index.php/skin/article/view/1528